Assessing User Satisfaction and Adherence to an Abbreviated Dietary Tracking App (MySnackTracker) Versus Full-intake Dietary Monitoring
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary Objectives The goal of the study is to compare the adherence and acceptability of tracking only high-energy low-nutrient value foods to standard full intake monitoring of diet. We predict that use of the high-energy, low-nutrient-density food tracking app will result in greater adherence to self-monitoring and greater satisfaction with monitoring in comparison to the full intake tracking.
Secondary Objectives Assess the efficacy of the snack tracking app versus standard self-monitoring as measured by changes in the following measures between baseline and follow up; percentage weight change, weight loss self-efficacy scores, food logging self-efficacy scores, GODIN leisure time activity questionnaire scores, Vioscreen tool responses for stages of change for fats and fruit/vegetable intake, daily fruit consumption, daily vegetable consumption, servings of sweets per day, Healthy Eating Index (HEI) Score for calories from solid fats, alcohols, added sugars, HEI empty calories, total drinks of alcohol per day, calories from alcoholic beverages per day, added sugars by available carbohydrates, added sugars by total grams of sugar, calorie intake, carbohydrate intake, fat intake, saturated fatty acid intake, and total sugar intake.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Karen M Basen-Engquist, MD
- Phone Number: 713-745-3123
- Email: kbasenen@mdanderson.org
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- MD Anderson Cancer Center
-
Contact:
- Karen M Basen-Engquist, MD
- Email: kbasenen@mdanderson.org
-
Principal Investigator:
- Karen M Basen-Engquist, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Eligibility Criteria
In order to be eligible to participate in this study, an participants must meet all of the following criteria:
- Provision of signed and dated informed consent form
- Access to internet connection, email address, and smartphone able to download the intervention app
- Current or previous participation in one of the following DFI cohorts: PA17-0584 (MERIT Study), Project CHURCH, High Risk Breast Cohort, Mexican-American Cohort, and rural cancer survivors from the Mind Your BEAT study
- Demonstrated ability to read and understand English. The study app is currently only available in English.
Exclusion Criteria
An participant who meets any of the following criteria will be excluded from participation in this study:
- Prisoners
- Anyone currently under 18 years of age
- Cognitively impaired participants
- Pregnant women (assessed by self-report)
- BMI less than 28 or greater than 40
- Self-reported previous or planned bariatric surgery
- Self-reported current or planned use of a GLP-1 agonist medication
- Self-reported current or planned participation in another weight loss intervention
- Cancer participants receiving active treatment
- Anyone currently unable to participate in the research for the duration of the study
- No current motivation to lose weight
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 2: Fitbit
Participants in Group 2, will use the Fitbit food logging app to track their dietary intake.
Participants will be asked to log all food and drink intake.
|
Wear it on wrist
|
|
Experimental: Group 1: MySnackTracker
Participants in Group 1 will use MySnackTracker to track their dietary intake.
Participants will be asked to log only high-calorie, low-nutrient food and drinks, or snacks" (for example, cookies, chips and dip, and alcohol).
A full list of these foods and drinks is provided in the app.
|
App to track your dietary intake
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Safety and adverse events
Time Frame: Through study completion; an average of 1 year
|
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events
|
Through study completion; an average of 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Karen M Basen-Engquist, MD, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2025-0163
- NCI-2025-02486 (Other Identifier: NCI-CTRP Clinical Registry)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.